Indian Hindi Web Series (2017–2022): Female Cops Questioning the Gender Binaries. Date Thursday, August 31, 2023 - 10:00 PM Description Media Watch; 09/01/2023(AN 171587355); ISSN: 09760911Business Source Corporate Plus
Indica vs. Sativa: Whats the Difference? Uses, Benefits, & More Date Wednesday, January 10, 2024 - 10:00 PM Description Sacramento Bee, The (CA); 01/11/2024(AN 2W6348140886)Business Source Corporate Plus
Indiva Announces Filing of Amended and Restated Offering Document and Concurrent Private Placement of up to $4.3 Million Date Tuesday, February 27, 2024 - 10:00 PM Description Business Wire (English); 02/28/2024(AN bizwire.20240228087111)Business Source Corporate Plus
Indiva Provides Corporate Update Including Improved Fourth Quarter Revenue Guidance Date Wednesday, January 03, 2024 - 10:00 PM Description Business Wire (English); 01/04/2024(AN bizwire.20240104313346)Business Source Corporate Plus
Indiva Reports Record Fiscal Year 2022 Results. Date Monday, May 01, 2023 - 10:00 PM Description Cannabis & Marijuana News; 05/02/2023(AN 163383067)Complementary Index
Indiva Reports Second Quarter 2023 Results. Date Monday, September 11, 2023 - 10:00 PM Description Cannabis & Marijuana News; 09/12/2023(AN 171821657)Complementary Index
Indiva Reports Third Quarter Results Including Record Revenue and Positive Income From Operations Date Monday, November 20, 2023 - 10:00 PM Description Business Wire (English); 11/21/2023(AN bizwire.20231121079553)Business Source Corporate Plus
Indivior Announces Four Abstracts Accepted for Presentation at the 85th Annual Scientific Meeting of the College on Problems of Drug Dependence Date Tuesday, June 13, 2023 - 10:00 PM Description PR Newswire US; 06/14/2023(AN 202306141353PR.NEWS.USPR.PH28977)Business Source Corporate Plus
Indivior Announces U.S. Food and Drug Administration Approval of OPVEE® (nalmefene) Nasal Spray, An Opioid Overdose Rescue Medicine for Natural and Synthetic Opioids Like Fentanyl Date Sunday, May 21, 2023 - 10:00 PM Description PR Newswire US; 05/22/2023(AN 202305221940PR.NEWS.USPR.PH07898)Business Source Corporate Plus
Indivior Completes Acquisition of Opiant Pharmaceuticals, Inc. Date Wednesday, March 01, 2023 - 10:00 PM Description PR Newswire US; 03/02/2023(AN 202303021014PR.NEWS.USPR.PH30432)Business Source Corporate Plus